|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales, net | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses (income): | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Gain on settlement of royalty obligation | |||||
| Total operating expenses, net | |||||
| Operating income | |||||
| Nonoperating income (expenses): | |||||
| Other income, net - Employee Retention Tax Credit | |||||
| Interest income, net | |||||
| Investment Income, Interest | |||||
| IRS ERTC disallowance | |||||
| Total nonoperating income, net | |||||
| Income before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income (loss) per share attributable to common stockholders | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...